Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab-Reference-Cited by-同舟云学术

Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab

Published:2016-05-25 Issue:12 Volume:10 Page:1407-1416
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Magro Fernando,Lopes Susana Isabel,Lopes Joanne,Portela Francisco,Cotter José,Lopes Sandra,Moreira Maria João,Lago Paula,Peixe Paula,Albuquerque Andreia,Rodrigues Susana,Silva Mário Rui,Monteiro Pedro,Lopes Castro,Monteiro Lucília,Macedo Guilherme,Veloso Luís,Camila Claudia,Afonso J.,Geboes Karel,Carneiro Fátima

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/10/12/1407/13746178/jjw112.pdf

Reference51 articles.

1. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease

2. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

3. Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease

4. Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

5. Mucosal healing in inflammatory bowel diseases: a systematic review

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study;Intestinal Research;2024-05-22

2. Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib;Journal of Crohn's and Colitis;2024-03-20

3. Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus;Inflammatory Bowel Diseases;2023-08-07

4. Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials;United European Gastroenterology Journal;2023-06-23

5. APOLLO Has Landed: PROMS and Histology in UC;Journal of Crohn's and Colitis;2023-03-25